• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Prostate Cancer Specialist Appointed Liaison to Cancer Commission
 

Prostate Cancer Specialist Appointed Liaison to Cancer Commission

on

  • 118 views

The Commission on Cancer is a consortium of 47 professional organizations dedicated to improving the survival and quality of life for cancer patients.

The Commission on Cancer is a consortium of 47 professional organizations dedicated to improving the survival and quality of life for cancer patients.

Statistics

Views

Total Views
118
Views on SlideShare
118
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Prostate Cancer Specialist Appointed Liaison to Cancer Commission Prostate Cancer Specialist Appointed Liaison to Cancer Commission Document Transcript

    • For Immediate Release April 12, 2013Contact: Damian Becker, Manager of Media Relations(516) 377-5370Dr. Wu Appointed Liaison to Cancer CommissionOceanside, NY— Leester D. Wu, MD, has been appointed South Nassau CommunitiesHospital’s Cancer Liaison Physician to the American College of Surgeons (ACS) Commissionon Cancer (CoC). Cancer Liaison Physicians are an integral part of cancer programs accreditedby the ACS.The CoC is a consortium of 47 professional organizations dedicated to improving thesurvival and quality of life for cancer patients. The Commission achieves its goal throughstandard-setting, cancer prevention, research, educational activities, as well as monitoringcomprehensive quality care.The Commission’s core functions include establishing standards to ensure the delivery ofquality, multidisciplinary, and comprehensive cancer care in health care settings; surveyingfacilities to assess compliance with those standards; collecting standardized data from accreditedfacilities to measure quality; using data to monitor treatment patterns, support cancer control, andenhance clinical surveillance activities; and developing effective educational interventions toimprove outcomes at the national, state, and local level. There are currently more than 1,400CoC-accredited cancer programs in the United States and Puerto Rico, and approximately 70percent of newly diagnosed cancer patients are treated in these institutions.“Our cancer care team is in the vanguard of developing and introducing the latestadvancements in treatment technologies and therapies and we place special emphasis on workingwith our patients and their families to develop patient-centered treatment plans,” said Dr. Wu,who is associate director of the department of radiation oncology at South Nassau. “I lookforward to working with my fellow colleagues and with the commission to offer the insight andinformation that will foster innovation and advancement in cancer care.”The three-year appointment places Dr. Wu among an elite group of approximately 1,600physicians who are recognized for their leadership in the development of cancer programs andfor their expertise in the diagnosis and treatment of cancer. Cancer Liaison Physicians areNews From:
    • responsible for spearheading CoC initiatives within their cancer program; collaborating withagencies, such as the American Cancer Society; and facilitating quality improvement initiativesutilizing data submitted to the CoCs National Cancer Database (NCDB). The CoC collects datafrom its accredited cancer programs and provides tools back to these facilities to facilitate theanalysis of patterns of diagnosis, treatment, and quality of care.Dr. Wu brings a diverse background in community practice and research to SouthNassau’s Radiation Oncology Department. He is a specialist in Intensity Modulated RadiationTherapy (IMRT), Image Guided Radiation Therapy (IGRT), prostate brachytherapy andstereotactic radiosurgery using the Gamma Knife.After completing his undergraduate studies at Harvard University, Dr. Wu earned hismedical degree at the University of Pennsylvania School of Medicine, where he completed ayear-long research project that examined the success of radiotherapy in the treatment of earlystage breast cancer. His research projects have been published in the International Journal ofRadiation Oncology and the Journal of Organic Chemistry and he has presented research atmajor meetings and conventions of radiation oncologists, including the American ChemicalSociety and American Society for Therapeutic Radiology and Oncology. Dr. Wu is boardcertified in radiation oncology and he is fluent in Taiwanese and conversant in Spanish.South Nassau Communities Hospital is one of the region’s largest hospitals, with 435beds, more than 900 physicians and 3,000 employees. Located in Oceanside, NY, the hospital isan acute-care, not-for-profit teaching hospital that provides state-of-the-art care in cardiac,oncologic, orthopedic, bariatric, pain management, mental health and emergency services. Inaddition to its extensive outpatient specialty centers, South Nassau provides emergency andelective angioplasty and is the only hospital on Long Island with the Novalis Tx™ and GammaKnife® Perfexion radiosurgery technologies. South Nassau is a designated Stroke Center by theNew York State Department of Health and Comprehensive Community Cancer Center by theAmerican College of Surgeons and is recognized as a Bariatric Surgery Center of Excellence bythe American Society for Metabolic and Bariatric Surgery. For more information, visitwww.southnassau.org.-30-